Brief: Neurovive Gets About SEK 99.0 Mln In Share Issue Proceeds
Feb 11 (Reuters) - NeuroVive Pharmaceutical AB NVP.ST :
* NEUROVIVE IS SUPPLIED WITH APPROXIMATELY MSEK 99.0 IN
SHARE
ISSUE PROCEEDS
* RIGHTS ISSUE HAS BEEN SUBSCRIBED TO APPROXIMATELY MSEK
74.5,
CORRESPONDING TO A SUBSCRIPTION RATIO OF APPROXIMATELY 60.2
PERCENT
Source text for Eikon: ID:nWkr7TR6RL
Further company coverage: NVP.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))